CS/HB 1617: Stem Cell Therapy
GENERAL BILL by Health Professions & Programs Subcommittee ; Buchanan ; (CO-INTRODUCERS) Black
Stem Cell Therapy; Authorizes licensed health care providers to perform stem cell therapy; specifies requirements for stem cells that may be used by such providers; requires such providers to adhere to applicable current good manufacturing practices in performance of such therapies; requires health care providers to provide specified written notice to patients before performing any stem cell therapy; specifies requirements for written notice; provides advertisement requirements; requires health care providers to obtain written consent from patient or his or her representative before performing therapy; specifies requirements for consent form; provides applicability; provides for disciplinary action; requires DOH to adopt rules.
Last Action: 4/4/2025 House - Now in Health & Human Services Committee
Bill Text: PDF
Bill History
| Date | Chamber | Action |
|---|---|---|
| 2/28/2025 | House |
• Filed |
| 3/4/2025 | House |
• 1st Reading (Original Filed Version) |
| 3/5/2025 | House |
• Referred to Health Professions & Programs Subcommittee • Referred to Health & Human Services Committee • Now in Health Professions & Programs Subcommittee |
| 4/1/2025 | House |
• Added to Health Professions & Programs Subcommittee agenda |
| 4/3/2025 | House |
• Favorable with CS by Health Professions & Programs Subcommittee • Reported out of Health Professions & Programs Subcommittee • Laid on Table under Rule 7.18(a) • CS Filed • 1st Reading (Committee Substitute 1) |
| 4/4/2025 | House |
• Referred to Health & Human Services Committee • Now in Health & Human Services Committee |
